Dr Michael Leach
- Honorary Clinical Senior Lecturer (School of Medicine, Dentistry & Nursing)
email:
Michael.Leach@glasgow.ac.uk
Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Shelley Road, Glasgow, G12 0YN
Publications
2023
Wilson, M. R. et al. (2023) ‘ACOPP’ chemotherapy for older and less fit patients with Hodgkin lymphoma—a multicentre, retrospective study. British Journal of Haematology, 202(4), pp. 796-800. (doi: 10.1111/bjh.18947) (PMID:37357380)
2014
Hamilton, R., Andrews, I., McKay, P. and Leach, M. (2014) Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography–computed tomography era: a West of Scotland study. Leukemia and Lymphoma, 55(5), pp. 1049-1052. (doi: 10.3109/10428194.2013.821201)
2013
McIlwaine, K. and Leach, M. T. J. (2013) Clostridium perfringens septicaemia. British Journal of Haematology, 163(5), p. 549. (doi: 10.1111/bjh.12551)
Cosimo, E. et al. (2013) Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes pro-survival stimuli to induce apoptosis in chronic lymphocytic leukemia cells. Clinical Cancer Research, 19(9), pp. 2393-2405. (doi: 10.1158/1078-0432.CCR-12-2170)
McIlwaine, L., Parker, A., Sandilands, G., Gallipoli, P. and Leach, M. (2013) Neutrophil-specific granule deficiency. British Journal of Haematology, 160(6), p. 735. (doi: 10.1111/bjh.12207)
2012
McKay, P., Leach, M., Jackson, R., Cook, G. and Rule, S. (2012) Guidelines for the investigation and management of mantle cell lymphoma. British Journal of Haematology, 159(4), pp. 405-426. (doi: 10.1111/bjh.12046)
2011
Farrell, K., McKay, P. and Leach, M. (2011) Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year followup in the West of Scotland Cancer Network. Leukemia and Lymphoma, 52(10), pp. 1920-1928. (doi: 10.3109/10428194.2011.584993)
2007
Gallipoli, P. and Leach, M. (2007) Gingival infiltration in acute monoblastic leukaemia. British Dental Journal, 203(9), pp. 507-509.
Melbourne, A., Atkinson, D., White, M., Collins, D., Leach, M. and Hawkes, D. (2007) Registration of dynamic contrast-enhanced MRI using a progressive principal component registration (PPCR). Physics in Medicine and Biology, 52(17), pp. 5147-5156.
2006
Gordon, W. and Leach, M. (2006) Lung carcinoma with anti-Hu paraneoplastic syndrome. New England Journal of Medicine, 355(5), E4-E4.
Hughes, M. and Leach, M. (2006) Dietary folate deficiency and bilateral retinal haemorrhages. Lancet, 368(9553), p. 2155.
2005
Moreton, P. et al. (2005) Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival. Journal of Clinical Oncology, 23(13), pp. 2971-2979.
O'Donnell, A. et al. (2005) A phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points. British Journal of Cancer, 93(8), pp. 876-883.
2004
Fragoso, M., Love, P., Verhaegen, F., Nalder, C., Bidmead, A., Leach, M. and Webb, S. (2004) The dose distribution of low dose rate Cs-137 in intracavitary brachytherapy: comparison of Monte Carlo simulation, treatment planning calculation and polymer gel measurement. Physics in Medicine and Biology, 49(24), pp. 5459-5474.
Hale, G. et al. (2004) Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration. Blood, 104(4), pp. 948-955.
2002
Leach, M. (2002) Retinal hemorrhages in acute leukemia. New England Journal of Medicine, 346(23), E6-E6.
Articles
Wilson, M. R. et al. (2023) ‘ACOPP’ chemotherapy for older and less fit patients with Hodgkin lymphoma—a multicentre, retrospective study. British Journal of Haematology, 202(4), pp. 796-800. (doi: 10.1111/bjh.18947) (PMID:37357380)
Hamilton, R., Andrews, I., McKay, P. and Leach, M. (2014) Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography–computed tomography era: a West of Scotland study. Leukemia and Lymphoma, 55(5), pp. 1049-1052. (doi: 10.3109/10428194.2013.821201)
McIlwaine, K. and Leach, M. T. J. (2013) Clostridium perfringens septicaemia. British Journal of Haematology, 163(5), p. 549. (doi: 10.1111/bjh.12551)
Cosimo, E. et al. (2013) Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes pro-survival stimuli to induce apoptosis in chronic lymphocytic leukemia cells. Clinical Cancer Research, 19(9), pp. 2393-2405. (doi: 10.1158/1078-0432.CCR-12-2170)
McIlwaine, L., Parker, A., Sandilands, G., Gallipoli, P. and Leach, M. (2013) Neutrophil-specific granule deficiency. British Journal of Haematology, 160(6), p. 735. (doi: 10.1111/bjh.12207)
McKay, P., Leach, M., Jackson, R., Cook, G. and Rule, S. (2012) Guidelines for the investigation and management of mantle cell lymphoma. British Journal of Haematology, 159(4), pp. 405-426. (doi: 10.1111/bjh.12046)
Farrell, K., McKay, P. and Leach, M. (2011) Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year followup in the West of Scotland Cancer Network. Leukemia and Lymphoma, 52(10), pp. 1920-1928. (doi: 10.3109/10428194.2011.584993)
Gallipoli, P. and Leach, M. (2007) Gingival infiltration in acute monoblastic leukaemia. British Dental Journal, 203(9), pp. 507-509.
Melbourne, A., Atkinson, D., White, M., Collins, D., Leach, M. and Hawkes, D. (2007) Registration of dynamic contrast-enhanced MRI using a progressive principal component registration (PPCR). Physics in Medicine and Biology, 52(17), pp. 5147-5156.
Gordon, W. and Leach, M. (2006) Lung carcinoma with anti-Hu paraneoplastic syndrome. New England Journal of Medicine, 355(5), E4-E4.
Hughes, M. and Leach, M. (2006) Dietary folate deficiency and bilateral retinal haemorrhages. Lancet, 368(9553), p. 2155.
Moreton, P. et al. (2005) Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival. Journal of Clinical Oncology, 23(13), pp. 2971-2979.
O'Donnell, A. et al. (2005) A phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points. British Journal of Cancer, 93(8), pp. 876-883.
Fragoso, M., Love, P., Verhaegen, F., Nalder, C., Bidmead, A., Leach, M. and Webb, S. (2004) The dose distribution of low dose rate Cs-137 in intracavitary brachytherapy: comparison of Monte Carlo simulation, treatment planning calculation and polymer gel measurement. Physics in Medicine and Biology, 49(24), pp. 5459-5474.
Hale, G. et al. (2004) Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration. Blood, 104(4), pp. 948-955.
Leach, M. (2002) Retinal hemorrhages in acute leukemia. New England Journal of Medicine, 346(23), E6-E6.